MedTrace Logo

Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male Volunteers

NCT01964365 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-02-13

No results posted yet for this study

Summary

The purpose of this study is to evaluate the pharmacokinetics profile and drug-drug interaction between rosuvastatin and fenofibric acid in healthy adult subjects

Conditions

  • Healthy

Interventions

DRUG

Cresto 20mg

tablet, rosuvastatin 20mg

DRUG

Fenofibric acid 135mg

capsule, fenofibric acid 135mg

DRUG

Cresto 20mg, Fenofibric acid 135mg

rosuvastatin 20mg, Fenofibric acid 135mg

Sponsors & Collaborators

  • Daewoong Pharmaceutical Co. LTD.

    lead INDUSTRY

Principal Investigators

  • Jae-Gook Shin, Professor · BUSAN PAIK HOSPITAL

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01964365 on ClinicalTrials.gov